Responses
Poster presentations
Clinical Supportive and Palliative Care
P 028
IS LONG-TERM LOW-MOLECULAR-WEIGHT HEPARIN STILL ACCEPTABLE TO PALLIATIVE CARE PATIENTS IN THE TREATMENT OF CANCER-ASSOCIATED THROMBOSIS? A QUALITATIVE STUDY REVISITED
Compose a Response to This Article
Other responses
No responses have been published for this article.